Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant

OBJECTIVES: The emergence of a SARS‐CoV‐2 variant with a point mutation in the spike (S) protein, D614G, has taken precedence over the original Wuhan isolate by May 2020. With an increased infection and transmission rate, it is imperative to determine whether antibodies induced against the D614 isol...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Clin Transl Immunology
المؤلفون الرئيسيون: Lee, Cheryl Yi‐Pin, Amrun, Siti Naqiah, Chee, Rhonda Sin‐Ling, Goh, Yun Shan, Mak, Tze‐Minn, Octavia, Sophie, Yeo, Nicholas Kim‐Wah, Chang, Zi Wei, Tay, Matthew Zirui, Torres‐Ruesta, Anthony, Carissimo, Guillaume, Poh, Chek Meng, Fong, Siew‐Wai, Bei, Wang, Lee, Sandy, Young, Barnaby Edward, Tan, Seow‐Yen, Leo, Yee‐Sin, Lye, David C, Lin, Raymond TP, Maurer‐Stroh, Sebastien, Lee, Bernett, Wang, Cheng‐I, Renia, Laurent, Ng, Lisa FP
التنسيق: Artigo
اللغة:Inglês
منشور في: John Wiley and Sons Inc. 2021
الموضوعات:
Short Communication
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7899292/
https://ncbi.nlm.nih.gov/pubmed/33628442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1241
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة